Trials / Conditions / Relapsed Hodgkin Lymphoma
Relapsed Hodgkin Lymphoma
4 registered clinical trials studyying Relapsed Hodgkin Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL NCT06484920 | Rita Assi | Phase 2 |
| Completed | Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Ref NCT04052997 | ADC Therapeutics S.A. | Phase 2 |
| Active Not Recruiting | Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma NCT04134325 | UNC Lineberger Comprehensive Cancer Center | EARLY_Phase 1 |
| Terminated | Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgki NCT02875067 | NYU Langone Health | Phase 1 / Phase 2 |